期刊
CHEMICAL RESEARCH IN TOXICOLOGY
卷 29, 期 12, 页码 2060-2070出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.chemrestox.6b00341
关键词
-
资金
- Unilever
The adverse outcome pathway (AOP) framework provides an alternative to traditional in vivo experiments for the risk assessment of chemicals. AOPs consist of a number of key events (KEs) linked by key event relationships across a range of biological organization backed by scientific evidence. The first ICE in the pathway is the molecular initiating event (MIE) the initial chemical trigger that starts an AOP. Over the past 3 years the AOP conceptual framework has gained a large amount of momentum in toxicology as an alternative to animal methods, and so the MIE has come into the spotlight. What is an MIE? How can MIEs be measured or predicted? What research is currently contributing to our understanding of MIEs? In this Perspective we outline answers to these key questions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据